Patients with vitiligo are often impacted mentally, and they can spend a lot of time utilizing cosmetic products, said David Rosmarin, MD, vice chair, education and research at Tufts Medical Center.
Vitiligo
Coverage of vitiligo treatments is variable and patients can face an economic burden in the form of direct and indirect costs, explained David Rosmarin, MD, vice chair, education and research at Tufts Medical Center.
Prior to this first therapy for repigmentation being approved, the only approved therapy was a depigmenting agent, which is usually the opposite of what providers are trying to accomplish with treatment.
A new awareness of vitiligo and new treatments coming to market is providing a multitude of options for treating the disease, said Brett King, MD, PhD, associate professor of dermatology, Yale School of Medicine.
Advertisement
Advertisement
Trending on AJMC
1
Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD
2
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
3
Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice
4
Efgartigimod Outperforms Standard IVIG in Averting Myasthenic Crisis
5
